Prognostic Value of the Geriatric Nutritional Risk Index in Previously Untreated Patients With Advanced NSCLC Treated With a Combination Therapy of Anti-PD-1/-PD-L1 Antibodies and Platinum-Based Chemotherapy: A Multicenter Retrospective Study.
Taro HirabayashiKei SoneharaRyota OzawaTsutomu HachiyaShuhei NozawaToshihiko AgatsumaHiroshi YamamotoAkane KatoAkemi MatsuoTaisuke ArakiMasamichi KomatsuKazunari TateishiMasayuki HanaokaPublished in: Oncology (2024)
The present study demonstrates that the GNRI is a useful prognostic predictor in patients with NSCLC treated with a combination therapy of anti-PD-1/-PD-L1 antibodies and platinum-based chemotherapy in clinical settings.